COPD International   Your Support Network

You can learn to control this disease instead of letting it control you!

 

Return To The Main Library         <<<<>>>>         Return To The HomePage

 
 

Safety Alert 
March 2003


Andrx Pharmaceuticals Has Recalled Diltia XT 
(anti-hypertensive and anti-angina medication)

The Food and Drug Administration (FDA) released the following information.

PRODUCT
Diltia XT, Extended Release Capsules,(Diltiazem HCl Extended Release
Capsules, USP), 120 mg, 100 and 1000 capsule bottles, Rx only. NDC 62037-
548-01(100's) and NDC 62037-548-10 (1000's). Recall # D-146-3.

CODE
548B002A, 548B002B, 548B003A ,548B003B, 548B004, 548B005A , 548B005B,
548B006 thru 548B010, 548C001,548C002A ,548C002B, 548C003, 548C004A and
548C004B,548C005 through 548C011A, 548C012C,548C012D, 548C013B and
548C014A.

RECALLING FIRM/MANUFACTURER
Andrx Pharmaceuticals, Inc., Fort Lauderdale, FL, by letter on November
27, 2002. Firm initiated recall ongoing.

REASON
Dissolution Failure: four hour time point (12 month stability station).

VOLUME OF PRODUCT IN COMMERCE
132,181 100's and 6,080 1000's.

DISTRIBUTION
Nationwide.

Send mail to: Webmaster@COPD-International.com with questions
or comments about this web site.
Copyright © 2002-2004 ----- COPD-International.com
Last modified:
March 8, 2003
Disclaimer